Mortality in Dravet syndrome
- PMID: 27810515
- DOI: 10.1016/j.eplepsyres.2016.10.006
Mortality in Dravet syndrome
Abstract
We measured the mortality rate and the rate of Sudden Unexpected Death in Epilepsy (SUDEP) in Dravet Syndrome (DS). We studied a cohort of 100 consecutively recruited, unrelated patients with DS; 87 had SCN1A mutations. Living cases had a median follow-up of 17 years. Seventeen patients died, at a median age of seven years (inter-quartile range 3-11 years) with causes of death: 10 SUDEP, four status epilepticus, two drowning and one asphyxia. The SUDEP classification included three Definite, one Definite Plus and six Probable. The Dravet-specific mortality rate/1000-person-years was 15.84 (98% CI 9.01-27.85). The Dravet-specific SUDEP rate was 9.32/1000-person-years (98% CI 4.46-19.45). The Dravet-specific SUDEP rate is the only documented syndrome-specific SUDEP rate. SUDEP in DS occurs mainly in childhood. It is also the highest SUDEP rate, considerably higher than the recent 5.1 SUDEP rate/1000-person-years for adults with refractory epilepsy.
Keywords: Dravet syndrome; Epilepsy; Mortality; Sudden unexpected death in epilepsy.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome.Epilepsia. 2011 Jun;52(6):1144-9. doi: 10.1111/j.1528-1167.2011.03053.x. Epub 2011 Apr 11. Epilepsia. 2011. PMID: 21480880
-
Two autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants.Brain Dev. 2020 Feb;42(2):171-178. doi: 10.1016/j.braindev.2019.10.005. Epub 2019 Oct 31. Brain Dev. 2020. PMID: 31677916
-
A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation.Epilepsia. 2010 Sep;51(9):1915-8. doi: 10.1111/j.1528-1167.2010.02691.x. Epilepsia. 2010. PMID: 20738378
-
Mortality in Dravet syndrome: A review.Epilepsy Behav. 2016 Nov;64(Pt A):69-74. doi: 10.1016/j.yebeh.2016.09.007. Epub 2016 Oct 11. Epilepsy Behav. 2016. PMID: 27732919 Review.
-
Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions.Respir Physiol Neurobiol. 2013 Nov 1;189(2):324-8. doi: 10.1016/j.resp.2013.06.026. Epub 2013 Jul 9. Respir Physiol Neurobiol. 2013. PMID: 23850567 Free PMC article. Review.
Cited by
-
A Mutation in the SCN1A Gene With a Peculiar Course: A Case Report.Cureus. 2021 Feb 28;13(2):e13612. doi: 10.7759/cureus.13612. Cureus. 2021. PMID: 33816011 Free PMC article.
-
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.Epilepsia. 2020 Nov;61(11):2386-2395. doi: 10.1111/epi.16638. Epub 2020 Aug 18. Epilepsia. 2020. PMID: 32809271 Free PMC article. Clinical Trial.
-
Current Treatment Strategies and Future Treatment Options for Dravet Syndrome.Curr Treat Options Neurol. 2018 Oct 13;20(12):52. doi: 10.1007/s11940-018-0537-y. Curr Treat Options Neurol. 2018. PMID: 30315507 Review.
-
Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial.Epilepsia. 2019 Feb;60(2):294-302. doi: 10.1111/epi.14628. Epub 2018 Dec 23. Epilepsia. 2019. PMID: 30582156 Free PMC article. Clinical Trial.
-
Rare and Complex Epilepsies from Childhood to Adulthood: Requirements for Separate Management or Scope for a Lifespan Holistic Approach?Curr Neurol Neurosci Rep. 2021 Nov 24;21(12):65. doi: 10.1007/s11910-021-01154-7. Curr Neurol Neurosci Rep. 2021. PMID: 34817708 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources